StockIsraelNasdaqCM

PYPD

PolyPid Ltd.

Healthcare · Biotechnology

5.20USD

-0.1300 (-2.44%)

Description Historical Financials Relative Value Research News Discussion OptionsPrice Chart ↗Fundamental Chart ↗

Fiscal Year End12/2025

Last Quarter End06/2026 Q2

Current/T12M(USD)

Issue Data

Last PxUSD / 5.20

P/E—

Dvd Ind Yld—

P/B19.60

P/S—

Curr EV/T12M EBITDA-3.3

Mkt Cap (USD)0.1B

Curr EV (USD)0.1B

Per Share Data

EPS T12M-1.48

DPS—

Bk Val Per Sh0.27

Rev/Sh—

Cash/Sh0.32

Curr Shares Out20.3M

FCF/Sh-1.24

Cash Flow Analysis

P/CF-3.8

Curr P/FCF-3.8

CF/NI0.9

Dvd P/O0.0%

Cash Gen/Cash Reqd—

Csh Dvd Cov—

CFO/Sales—

Eff Interest Rate22.8%

Growth Potential

Dil EPS 1Y Gr-27.7%

Cap 1Y Gr-20.8%

BPS 1Y Gr54.9%

R&D To Sales—

Retention Rate100.0%

Rev 1Y Gr—

FCF 1Y Gr-27.5%

Assets 1Y Gr-11.6%

Profitability

EBITDA-0.0B

EBIT-0.0B

Operating Margin0.0%

Pretax Margin—

Net Margin0.0%

ROA-119.0%

ROE-243.6%

ROC-480.9%

Asset Turnover—

Structure

Current Ratio1.35

Quick Ratio0.99

Debt/Assets7.8%

Debt/Com Eq21.9%

Net Debt/EBITDA0.17

Tot Debt/Capital18.0%

Gross Margin0.0%

EBIT/Int Exp-36.1

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.

Reading financial statements from SEC filings…

A first visit to a security takes a few seconds.